M&T Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,403
| Closed | -$475K | – | 1709 |
|
|
2024
Q4 | $475K | Sell |
38,403
-65,317
| -63% | -$748K | ﹤0.01% | 1191 |
|
|
2024
Q3 | $1.18M | Buy |
103,720
+237
| +0.2% | +$2.38K | ﹤0.01% | 838 |
|
|
2024
Q2 | $739K | Sell |
103,483
-84
| -0.1% | -$643 | ﹤0.01% | 967 |
|
|
2024
Q1 | $694K | Buy |
103,567
+135
| +0.1% | +$929 | ﹤0.01% | 1012 |
|
|
2023
Q4 | $673K | Buy |
103,432
+17,673
| +21% | +$114K | ﹤0.01% | 1014 |
|
|
2023
Q3 | $810K | Buy |
85,759
+5,231
| +6% | +$63K | ﹤0.01% | 917 |
|
|
2023
Q2 | $1.13M | Buy |
80,528
+15,411
| +24% | +$263K | ﹤0.01% | 825 |
|
|
2023
Q1 | $1.22M | Sell |
65,117
-8,917
| -12% | -$146K | ﹤0.01% | 787 |
|
|
2022
Q4 | $1.02M | Sell |
74,034
-112
| -0.2% | -$1.72K | ﹤0.01% | 848 |
|
|
2022
Q3 | $1.42M | Buy |
74,146
+305
| +0.4% | +$5.56K | 0.01% | 699 |
|
|
2022
Q2 | $1.13M | Sell |
73,841
-591
| -0.8% | -$8.74K | 0.01% | 736 |
|
|
2022
Q1 | $1.51M | Buy |
74,432
+37,206
| +100% | +$758K | 0.01% | 640 |
|
|
2021
Q4 | $1.09M | Sell |
37,226
-1,356
| -4% | -$38.8K | ﹤0.01% | 748 |
|
|
2021
Q3 | $832K | Hold |
38,582
| – | – | ﹤0.01% | 813 |
|
|
2021
Q2 | $990K | Sell |
38,582
-9,272
| -19% | -$198K | ﹤0.01% | 757 |
|
|
2021
Q1 | $872K | Sell |
47,854
-9,481
| -17% | -$158K | ﹤0.01% | 790 |
|
|
2020
Q4 | $662K | Hold |
57,335
| – | – | ﹤0.01% | 920 |
|
|
2020
Q3 | $437K | Buy |
57,335
+6,070
| +12% | +$46K | ﹤0.01% | 1054 |
|
|
2020
Q2 | $337K | Buy |
51,265
+211
| +0.4% | +$1.18K | ﹤0.01% | 1132 |
|
|
2020
Q1 | $261K | Buy |
51,054
+7,620
| +18% | +$46.1K | ﹤0.01% | 1201 |
|
|
2019
Q4 | $333K | Sell |
43,434
-4,406
| -9% | -$25.7K | ﹤0.01% | 1033 |
|
|
2019
Q3 | $254K | Hold |
47,840
| – | – | ﹤0.01% | 1298 |
|
|
2019
Q2 | $268K | Hold |
47,840
| – | – | ﹤0.01% | 1287 |
|
|
2019
Q1 | $203K | Buy |
47,840
+5,781
| +14% | +$23.6K | ﹤0.01% | 1411 |
|
|
2018
Q4 | $172K | Buy |
42,059
+6,659
| +19% | +$34.7K | ﹤0.01% | 1314 |
|
|
2018
Q3 | $243K | Buy |
+35,400
| New | +$210K | ﹤0.01% | 1337 |
|
|
2014
Q4 | – | Sell |
-3,007
| Closed | -$29K | – | 2263 |
|
|
2014
Q3 | $29K | Buy |
+3,007
| New | +$33.7K | ﹤0.01% | 2127 |
|
Other funds holding CDMO
M&T Bank's CDMO Position: Q1 2025 in Review
M&T Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 38,403 shares — an estimated $475K sold.
M&T Bank first reported a position in CDMO in Q3 2014 and held it in 27 quarters. The position peaked at $1.51M in Q1 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- M&T Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- M&T Bank sold 38,403 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $475K.
- M&T Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2014 and held it in 27 quarters.
- M&T Bank's Avid Bioservices, Inc. Common Stock position peaked at $1.51M in Q1 2022.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.